Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr 20;14(9):1703.
doi: 10.3390/nu14091703.

Economic Evaluation of Individualized Nutritional Support for Hospitalized Patients with Chronic Heart Failure

Affiliations
Randomized Controlled Trial

Economic Evaluation of Individualized Nutritional Support for Hospitalized Patients with Chronic Heart Failure

Philipp Schuetz et al. Nutrients. .

Abstract

Background Malnutrition is a highly prevalent risk factor in hospitalized patients with chronic heart failure (CHF). A recent randomized trial found lower mortality and improved health outcomes when CHF patients with nutritional risk received individualized nutritional treatment. Objective To estimate the cost-effectiveness of individualized nutritional support in hospitalized patients with CHF. Methods This analysis used data from CHF patients at risk of malnutrition (N = 645) who were part of the Effect of Early Nutritional Therapy on Frailty, Functional Outcomes and Recovery of Undernourished Medical Inpatients Trial (EFFORT). Study patients with CHF were randomized into (i) an intervention group (individualized nutritional support to reach energy, protein, and micronutrient goals) or (ii) a control group (receiving standard hospital food). We used a Markov model with daily cycles (over a 6-month interval) to estimate hospital costs and health outcomes in the comparator groups, thus modeling cost-effectiveness ratios of nutritional interventions. Results With nutritional support, the modeled total additional cost over the 6-month interval was 15,159 Swiss Francs (SF). With an additional 5.77 life days, the overall incremental cost-effectiveness ratio for nutritional support vs. no nutritional support was 2625 SF per life day gained. In terms of complications, patients receiving nutritional support had a cost savings of 6214 SF and an additional 4.11 life days without complications, yielding an incremental cost-effectiveness ratio for avoided complications of 1513 SF per life day gained. Conclusions On the basis of a Markov model, this economic analysis found that in-hospital nutritional support for CHF patients increased life expectancy at an acceptable incremental cost-effectiveness ratio.

Keywords: chronic heart failure; clinical outcomes; cost savings; economic analysis; nutritional support.

PubMed Disclaimer

Conflict of interest statement

The initial study was investigator-initiated and supported by a grant from the Swiss National Science Foundation to P. Schuetz (SNSF Professorship, PP00P3_150531) and the Forschungsrat of the Kantonsspital Aarau (1410.000.058 and 1410.000.044). The institution of P. Schuetz previously received unrestricted grant money unrelated to this project from Nestlé Health Science and Abbott Nutrition. The institution of Z. Stanga received speaking honoraria and research support from Nestlé Health Science, Abbott Nutrition, and Fresenius Kabi. S. Sulo and C. Brunton are employees and stockholders of Abbott. S. Walzer and S. Krenberger received funding for the model development by Abbott. S. Walzer has also received funding from Nestlé and Fresenius Kabi for health economic support. All other authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Health states of the Markov model. Light blue arrows represent patients staying within the given health state, while bright blue arrows represent transitions between states. Abbreviation: ICU, intensive care unit.

Similar articles

Cited by

References

    1. Lippi G., Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med. J. 2020;5:1–6. doi: 10.21037/amj.2020.03.03. - DOI
    1. Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Das S.R., et al. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
    1. Urbich M., Globe G., Pantiri K., Heisen M., Bennison C., Wirtz H.S., Tanna G.L.D. A systematic review of medical costs associated with heart failure in the USA (2014–2020) Pharmacoeconomics. 2020;38:1219–1236. doi: 10.1007/s40273-020-00952-0. - DOI - PMC - PubMed
    1. Groenewegen A., Rutten F.H., Mosterd A., Hoes A.W. Epidemiology of heart failure. Eur. J. Heart Fail. 2020;22:1342–1356. doi: 10.1002/ejhf.1858. - DOI - PMC - PubMed
    1. Andreae C., Stromberg A., Arestedt K. Prevalence and associated factors for decreased appetite among patients with stable heart failure. J. Clin. Nurs. 2016;25:1703–1712. doi: 10.1111/jocn.13220. - DOI - PubMed

Publication types

Grants and funding